Research Topic · Peer-Reviewed

SARS

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, SARS-CoV, first recognised in an outbreak that began in 2002 to 2003 and spread internationally. The disease is characterised by fever and lower respiratory involvement that can progress to severe pneumonia and respirato…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 15× across the literature 🔖 ISSN 2576-9383 🗓 Reviewed July 2026

Overview

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, SARS-CoV, first recognised in an outbreak that began in 2002 to 2003 and spread internationally. The disease is characterised by fever and lower respiratory involvement that can progress to severe pneumonia and respiratory failure, and it is transmitted chiefly through respiratory droplets and close contact. SARS-CoV belongs to the betacoronaviruses, an enveloped, positive-sense single-stranded RNA virus family that also includes SARS-CoV-2, the agent of COVID-19; the spike glycoprotein mediates host-cell entry and is a focus of evolutionary and immunological study. Research in this area, much of it prompted by the closely related SARS-CoV-2 pandemic, examines the molecular evolution and phylogenetic relationships of these coronaviruses through spike-gene and genomic analysis, viral kinetics under antiviral regimens, intracellular replication cycles, mutation prediction, variant screening, and host immune and cytokine responses, including the role of convalescent plasma and neutralising antibodies. Related strands address pathogenesis, immunity, and therapeutic strategy. The topic matters because coronavirus emergence poses a continuing threat to global health, and understanding viral evolution, transmission, and host response informs surveillance, treatment, and vaccine development. The journal publishes peer-reviewed research on coronavirus biology, molecular evolution, and the clinical and immunological aspects of these infections.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 15 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on SARS, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Human Health Research (ISSN 2576-9383).

Journal editorial board
Irma Brito · Portugal Suelen Boschen · United States Mohammad Nahid Siddiqui · Saudi Arabia

This page summarises published research for orientation; it is not medical or professional advice.